VHCP Management III, LLC

FollowCreate a free account to set a filing alert.

10% owner at Oruka Therapeutics, Inc. · on record since Feb 27, 2025
10% owner at Bellerophon Therapeutics, Inc. · on record since Sep 17, 2018
10% owner at KalVista Pharmaceuticals, Inc. · on record since Sep 10, 2018
10% owner at CONSTAR INTERNATIONAL INC · on record since Dec 16, 2019
10% owner at Synvista Therapeutics, Inc. · on record since May 28, 2020
10% owner at Cogent, Inc. · on record since Aug 18, 2020
10% owner at Tricida, Inc. · on record since Jun 30, 2022
10% owner at Vistagen Therapeutics, Inc. · on record since Jul 14, 2022
10% owner at Lycia Therapeutics, Inc. · on record since Oct 22, 2026

Insider trading activity of VHCP Management III, LLC

Transactions on record: 19; since Sep 17, 2018

Purchases: 17; $13.7M

Sales: 0

Companies traded: 4; last filing Feb 27, 2025

Figures computed from official regulatory filings — .

Companies where VHCP Management III, LLC has traded

Oruka Therapeutics, Inc.5 tx · $1.4M · Feb 27, 2025
KalVista Pharmaceuticals, Inc.3 tx · $621.6K · Feb 3, 2025
Synvista Therapeutics, Inc.8 tx · $11.4M · Mar 1, 2021
Bellerophon Therapeutics, Inc.3 tx · $252.3K · Sep 17, 2018

Track record of VHCP Management III, LLC

Statistical track record

Free account

Purchases: 17

Last buy: Feb 14, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of VHCP Management III, LLC

Co-insiders of VHCP Management III, LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	88,794	11.44 USD	$1M	conv 31	SEC
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	574	10.90 USD	$6.3K	conv 29	SEC
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	9,593	10.95 USD	$105K	conv 29	SEC
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	14,950	11.63 USD	$173.9K	conv 29	SEC
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	8,971	11.86 USD	$106.4K	conv 29	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 3, 2025	Buy	43,707	8.76 USD	$382.9K	conv 33First in 12mo	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 3, 2025	Buy	14,562	9.22 USD	$134.3K	conv 20	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 3, 2025	Buy	11,754	8.89 USD	$104.5K	conv 19	SEC
Synvista Therapeutics, Inc.Listing unverified	Mar 1, 2021	Other	-1,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Synvista Therapeutics, Inc.Listing unverified	Mar 1, 2021	OtherD (derivative)	1,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	125,162	7.23 USD	$904.9K	conv 9	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	277,000	7.92 USD	$2.2M	conv 16	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	173,711	8.87 USD	$1.5M	conv 10	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	390,547	9.78 USD	$3.8M	conv 61Unusual sizeFirst in 12mo	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	309,453	8.79 USD	$2.7M	conv 61Unusual sizeFirst in 12mo	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	27,763	7.79 USD	$216.3K	conv 7	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	60,000	1.18 USD	$70.8K	conv 33Cluster	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	75,000	1.19 USD	$89.3K	conv 41ClusterFirst in 12mo	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	75,000	1.23 USD	$92.3K	conv 33Cluster	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	88,794	11.44 USD	$1M	conv 31	SEC
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	574	10.90 USD	$6.3K	conv 29	SEC
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	9,593	10.95 USD	$105K	conv 29	SEC
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	14,950	11.63 USD	$173.9K	conv 29	SEC
Oruka Therapeutics, Inc.Listing on record	Feb 27, 2025	Buy	8,971	11.86 USD	$106.4K	conv 29	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 3, 2025	Buy	43,707	8.76 USD	$382.9K	conv 33First in 12mo	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 3, 2025	Buy	14,562	9.22 USD	$134.3K	conv 20	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Feb 3, 2025	Buy	11,754	8.89 USD	$104.5K	conv 19	SEC
Synvista Therapeutics, Inc.Listing unverified	Mar 1, 2021	Other	-1,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Synvista Therapeutics, Inc.Listing unverified	Mar 1, 2021	OtherD (derivative)	1,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	125,162	7.23 USD	$904.9K	conv 9	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	277,000	7.92 USD	$2.2M	conv 16	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	173,711	8.87 USD	$1.5M	conv 10	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	390,547	9.78 USD	$3.8M	conv 61Unusual sizeFirst in 12mo	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	309,453	8.79 USD	$2.7M	conv 61Unusual sizeFirst in 12mo	SEC
Synvista Therapeutics, Inc.Listing unverified	May 28, 2020	Buy	27,763	7.79 USD	$216.3K	conv 7	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	60,000	1.18 USD	$70.8K	conv 33Cluster	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	75,000	1.19 USD	$89.3K	conv 41ClusterFirst in 12mo	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	75,000	1.23 USD	$92.3K	conv 33Cluster	SEC